TRU
Truscreen Group Limited
๐ฆ๐บ ASX
๐ฉบ HEALTH CARE
๐ Overview
๐ Performance
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
-19.65%
Annual Growth
4 years average annual growth
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
1
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
TruScreen Group Ltd. engages in the development, manufacture, and sale of cancer detection device and systems. The firm is engaged in the development of an artificial intelligence (AI)-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. The Companyโs cervical screening technology resolves ongoing issues with cytology, including failed samples, poor patient follow-up, patient discomfort, and the need for supporting laboratory infrastructure. The TruScreen device uses opto-electrical technology to evaluate the tissue of the cervix. The TruScreen device consists of a disposable Single Use Sensor (SUS), a Handheld Device (HHD), and an Intelligent Cradle (IC) which works together to detect and identify cancerous and precancerous changes to the cervix. The company also resolves the problems associated with human papillomavirus (HPV) testing, which tests for the much more prevalent HPV virus.
๐ Performance
Price History
-72.86%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
0%
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$0.02
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in TRU
0
๐ Total Capital Earnings
$-332.55
๐ Average investment frequency
32 weeks
๐ต Average investment amount
$820
โฐ Last time a customer invested in TRU
833 days
TRU investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
๐ Legal gender of investors
Female
Male
Pearlers who invest in TRU also invest in...
VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
๐ Performance (5Yr p.a)
16.86%
๐ Share price
$414.11 AUD
๐บ๐ธ UNITED STATES
๐ GLOBAL
๐ค TECHNOLOGY
โณ๏ธ DIVERSIFIED
๐ HIGH PRICE GROWTH
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
๐ Performance (5Yr p.a)
10.38%
๐ Share price
$35.34 AUD
๐ HIGH PRICE GROWTH
๐ฆ๐บ EX AUSTRALIA
๐ค TECHNOLOGY
๐ฉบ HEALTH CARE
VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax
๐ Performance (5Yr p.a)
13.74%
๐ Share price
$91.70 AUD
๐ GLOBAL
๐ค TECHNOLOGY
โณ๏ธ DIVERSIFIED
๐ HIGH PRICE GROWTH
VEU.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard All-World ex-US Shares Index ETF seeks to track the return of the FTSE All-World ex US Index before taking into account fees, expenses and tax
๐ Performance (5Yr p.a)
4.34%
๐ Share price
$90.98 AUD
โณ๏ธ DIVERSIFIED
๐ GLOBAL
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
๐ Performance (5Yr p.a)
17.69%
๐ Share price
$55.95 AUD
๐ HIGH PRICE GROWTH
๐บ๐ธ UNITED STATES
Want more shares? Try these...
Top Shelf International Holdings Ltd. engages in manufacturing and distributes non-alcoholic and alcoholic beverages. The Companyโs brands are NED Australian Whisky and Grainshaker Hand Made Australian Vodka. The firm has expertise in the development and production of distilled spirits, undertakes a significant level of research and development and operates modern fermentation, distillation and packaging facilities in Campbellfield, Victoria. The firm also provides canning, bottling, and packaging services to a range of customers. NED is a whisky in Australia that comes in both bottle and ready-to-serve formats. The Companyโs maturation facilities and bond stores are located in Somerton, Victoria, and house oak vats and barrels for the storage of whisky inventory. The Companyโs Agave spirit farm is situated in the Whitsundays region of Queensland.
๐ Share price
$0.04 AUD
๐ FOOD PRODUCTS
Tissue Repair Ltd. is a clinical stage bio pharmaceutical company, which develops advanced wound healing products targeting applications in the chronic wound and aesthetic procedure aftercare markets, with the potential for further development of related technologies. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-11-18. The firm's core focus is entering Phase 3 clinical trials in chronic wounds for its lead drug candidate TR987, with a secondary focus on commercializing TR Pro+ a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its TR Pro+ product provides a range of benefits that assists damaged skin to heal and maintains skin hydration for a moist healing environment to encourage normal scar formation. The firm is also focused on commercializing its propriety Glucoprime active pharmaceutical ingredient (API) to treat a variety of wounds and skin conditions. Glucoprime is a ฮฒ-glucan molecule, which is designed to assist skin healing and is delivered topically in a hydrogel formulation.
๐ Share price
$0.48 AUD
๐งฌ BIOTECHNOLOGY
The Reject Shop Ltd. engages in retailing discount variety merchandise. The firm specializes in in curating furniture items that are on surplus clearance and factory rejects due to minor cosmetic defects. The company sells a range of furniture items that are brand new but have been rejected due to minor defects or damages during the manufacturing process. These items are sold at a lower price compared to similar products available in the market. Its product categories include dining room, living room, bedroom, outdoor, delivery options, office, luxury goods, homeware and appliance, home decor, electronics, and lighting. Its dining room products include HOVE Oval Dining Table in WALNUT, LORRAINE Outdoor Table in GREY, CHUNGHA Carrara Marble Dining Table with WALNUT Frame, BINNA Dining Table in OAK, and DALMASSE Small V-Frame Square Dining Table in NATURAL. Its luxury products include Louis Vuitton Handbag Preloved and TODS Handbag Preloved.
๐ Performance (5Yr p.a)
13.60%
๐ Share price
$3.10 AUD
๐ HIGH PRICE GROWTH
๐๏ธ CONSUMER